Samuel A. Shelburne, Pranoti Sahasrabhojane, Miguel Saldana, Hui Yao, Xiaoping Su, Nicola Horstmann, Erika Thompson, Anthony R. Flores, “Streptococcus mitisStrains Causing Severe Clinical Disease in Cancer Patients”, Emerg. Infect. Dis., 20, no. 5, 2014, 762
Fuensanta Guerrero-Del-Cueto, Cyntia Ibanes-Gutiérrez, Consuelo Velázquez-Acosta, Patricia Cornejo-Juárez, Diana Vilar-Compte, “Microbiology and clinical characteristics of viridans group streptococci in patients with cancer”, The Brazilian Journal of Infectious Diseases, 22, no. 4, 2018, 323
Thomas Lehrnbecher, Lillian Sung, “Anti-infective prophylaxis in pediatric patients with acute myeloid leukemia”, Expert Review of Hematology, 7, no. 6, 2014, 819
Arne Simon, Nora Gröger, Anja Wilkesmann, Carola Hasan, Gertrud Wiszniewsky, Steffen Engelhart, Michael H. Kramer, Udo Bode, Roland A. Ammann, Gudrun Fleischhack, “Restricted use of glycopeptides in paediatric cancer patients with fever and neutropenia”, International Journal of Antimicrobial Agents, 28, no. 5, 2006, 417
Anne F. Reilly, Beverly J. Lange, “Infections with viridans group streptococci in children with cancer”, Pediatric Blood & Cancer, 49, no. 6, 2007, 774
Sejong Chun, Hee Jae Huh, Nam Yong Lee, “Species-Specific Difference in Antimicrobial Susceptibility Among Viridans Group Streptococci”, Ann Lab Med, 35, no. 2, 2015, 205
Kent A. Sepkowitz, “Treatment of Patients with Hematologic Neoplasm, Fever, and Neutropenia”, Clinical Infectious Diseases, 40, no. Supplement_4, 2005, S253
Andreas H. Groll, Arne Simon, Thomas Lehrnbecher, Pädiatrische Hämatologie und Onkologie, 2006, 978
Thomas J Pallasch, “Antibiotic resistance”, Dental Clinics of North America, 47, no. 4, 2003, 623
Chia-Ter Chao, Szu-Ying Lee, Wei-Shun Yang, Huei-Wen Chen, Cheng-Chung Fang, Chung-Jen Yen, Chih-Kang Chiang, Kuan-Yu Hung, Jenq-Wen Huang, “Viridans Streptococci in Peritoneal Dialysis Peritonitis: Clinical Courses and Long-Term Outcomes”, Perit Dial Int, 35, no. 3, 2015, 333